BAC vs INCY Stock Comparison

INCY currently leads BAC in this stock comparison, with AIQ scores of 64 vs 46. The clearest difference is quality, while BAC has the stronger value profile.

Market data as of Oct 21, 2026 market close· AIQ score gap 18 points
BAC
Financial Services
vs
INCY
Healthcare
BAC
Bank of America Corporation
Price
$50.78
Day move
+0.28%
AIQ Score
46/100
Best edge
Value
Sector
Financial Services
INCY
Incyte Corporation
Leads
Price
$113
Day move
-2.72%
AIQ Score
64/100
Best edge
Quality
Sector
Healthcare

What is the main difference between BAC and INCY?

INCY leads the current stock comparison as Incyte Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Incyte Corporation

Data as of Oct 21, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

INCY leads

INCY leads by 18 AIQ points, primarily on Quality and Momentum, but the lead has narrowed from 24 points over 30 sessions. Wall Street currently favors BAC on target upside.

Stable: 4 of 6 evidence groups support INCY, its lead is narrowing, and its signal state is cleanly positive.

Evidence agreement: 4 of 6Comparison trend: Weakening
BAC

Bank of America Corporation

AIQ Score
46/100
AIQ Edge Score
3/10
INCY

Incyte Corporation

Leads
AIQ Score
64/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors INCY over BAC, 64 versus 46 as of Oct 21, 2026. INCY's advantage is driven primarily by stronger quality and momentum, while BAC holds the stronger value profile. INCY also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 4 of 6 covered evidence groups favor INCY today, and the comparison is rated Stable on stability: the leader's advantage has been narrowing. INCY lead: Weakening — the AIQ differential moved from 24 to 18 points over 30 sessions.

Compare Bank of America Corporation and Incyte Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+20.3%
INCY
+77.3%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,032 · INCY $17,725

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and INCY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
INCY advantage
  • Quality49 vs 90
    INCY +41
  • Momentum24 vs 40
    INCY +16
  • Risk Resilience58 vs 74
    INCY +16
  • Value57 vs 52
    BAC +5

4 of 6 evidence groups favor INCY. INCY’s edge is concentrated in quality and momentum; BAC keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.

BAC0 AIQ

Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

INCY+3 AIQ

Largest factor move: Momentum +10

New signals

  • MACD Bullish Crossover — bullish, momentum, short horizon

INCY's lead widened by 3 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and INCY both carry a full feed there.

The central trade-off

INCY (Incyte Corporation): the stronger current systematic profile, led by quality and momentum.

BAC (Bank of America Corporation): the counter-case, on value, valuation, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

INCY

INCY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

INCY

INCY on combined revenue and EPS growth.

Value

BAC

BAC on the peer-relative Value factor, by 5 points.

Momentum

INCY

INCY on the Momentum factor, by 16 points.

Lower downside

INCY

INCY on Risk Resilience, by 16 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors INCY, analyst targets favor BAC. That disagreement is the most useful thing on this page.

MeasureBACINCYNote
Implied upside to target+30.5%+9.9%BAC has more room
Target dispersion+22.6%+53.7%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering1115Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor INCY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreINCY46 vs 64
FundamentalsINCYrevenue growth -3.3% vs 31.5%; EPS growth -23.8% vs 92.1%; TTM ROE 10.7% vs 29.7%; gross margin 60.4% vs 92.6%; operating margin 22.4% vs 31.6%
ValuationBACValue 57 vs 52
TechnicalsINCYPrice vs 50-day -13.2% vs -6.7%; vs 200-day -8.1% vs 8.3%
Risk ResilienceINCYRisk Resilience 58 vs 74
Analyst expectationsBACTarget upside 30.5% vs 9.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and INCY and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 18 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INCY.

How the comparison changed

120 daily snapshots · Jun 21 – Oct 20

INCY lead: Weakening — the AIQ differential moved from 24 to 18 points over 30 sessions.

Jun 21BAC leads above the line · INCY leads belowOct 20
Today
INCY +18
46 vs 64
7 sessions ago
INCY +20
41 vs 61
30 sessions ago
INCY +24
40 vs 64
90 sessions ago
INCY +11
54 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce — bullish, momentum, short horizon
  • MACD Bearish Crossover — bearish, momentum, short horizon
INCY

2 bullish / 0 bearish

Only INCY

  • MACD Bullish Crossover — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: Golden Cross Active.

BAC is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.28%, AIQ 0 points).

INCYDivergence

Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -2.72%, AIQ +3 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Quality gap — currently 41 points behind, the largest single contributor to INCY's edge.
  2. 2BAC's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
  3. 3INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4The narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 18-point move would eliminate INCY's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

INCY leads on balance
MetricBACINCY
Revenue growth (YoY)-3.3%31.5%
EPS growth (YoY)-23.8%92.1%
Gross margin60.4%92.6%
Operating margin22.4%31.6%
Return on equity (TTM)10.7%29.7%
Debt to equity1.280.01

Performance

INCY leads 6 of 6 windows
MetricBACINCY
1 week (5 sessions)-6.2%7.4%
1 month (20 sessions)-9.9%-8.1%
3 months (63 sessions)-16.5%0.7%
6 months (126 sessions)-5.3%21.2%
Year to date-7.9%18.1%
1 year (252 sessions)0.4%33.6%

Technicals

INCY has the stronger structure
MetricBACINCY
RSI (14)25.539.5
ADX (14)48.625.2
Price vs 50-day-13.2%-6.7%
Price vs 200-day-8.1%8.3%
Volatility (1M, annualized)21.8%25.4%

Risk

INCY is the more resilient
MetricBACINCY
Beta0.750.4
Sharpe ratio-0.130.91
Sortino ratio-0.161.55
Max drawdown-22.3%-18.3%
Current drawdown-21.9%-10.3%
Annualized volatility21.9%33.4%
Value at risk (95%)-2.5%-2.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or INCY?

On the Algovestiq AIQ Score, INCY is the stronger of the two as of Oct 21, 2026, scoring 64 against BAC's 46. The edge comes from quality and momentum. BAC is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or INCY the better buy right now?

INCY carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor INCY over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. INCY leads Quality by 41 points; INCY leads Momentum by 16 points; INCY leads Risk Resilience by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or INCY?

Analyst price targets imply +30.5% upside for BAC and +9.9% for INCY, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors INCY. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or INCY?

BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 5 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or INCY?

INCY on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or INCY?

INCY on the Momentum factor, by 16 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or INCY?

INCY is the more resilient of the two, so the other name carries the higher downside risk. INCY on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than INCY?

INCY leads on the comparable margin measures — gross margin 60.4% vs 92.6%; operating margin 22.4% vs 31.6%; ttm roe 10.7% vs 29.7%.

Is INCY's lead over BAC getting stronger or weaker?

INCY lead: Weakening — the AIQ differential moved from 24 to 18 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.

What would change the BAC vs INCY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Quality gap — currently 41 points behind, the largest single contributor to INCY's edge; BAC's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 18-point move would eliminate INCY's advantage entirely.

What do the current signals say about BAC and INCY?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. INCY: 2 bullish / 0 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Golden Cross Active (bullish, long horizon). On INCY it is Golden Cross Active (bullish, long horizon).

Compare BAC and INCY with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.